Transcript Highlights:

• COMPETITION AND AFFORDABILITY WHEN IT COMES TO OUR PRESCRIPTION DRUG MARKET.
• Very drugs that they are selling on the street? Through you, Mr.
• President, this bill doesn't protect a drug dealer.
• >> I THINK THE BIGGEST FAILURE HAS BEEN THE WAR ON DRUGS.
• The war on drugs was a failure.

Summary: The Senate convened, approved the journal, and took up a series of motions to discharge identical Assembly bills to the Third Reading Calendar, along with committee reports and amendments. The chamber also received an introduction from Senator Gonzalez honoring Maria Raine and her advocacy for guardrails on AI chatbots after the death of her son, and later adopted a Rules Committee report sending several General Business Law bills directly to Third Reading. The resolution calendar was adopted with some exceptions, and the Senate recognized several previously adopted resolutions honoring individuals and observances, including Barnabas McHenry, Arthur Jones Jr., Floyd Todd Peterson III, the Lexington School for the Deaf, Tadeusz Kosciuszko, Apraxia Awareness Month, Fibromyalgia Awareness Day, Prevention Week, Physician Anesthesiologists Week, and Golf Day in New York. The Senate then considered and passed numerous bills, many on consumer protection and public policy topics. Measures included bills on General Business Law, Public Health Law, Correction Law, Environmental Conservation Law, Executive Law, Vehicle and Traffic Law, Public Officers Law, Not-for-Profit Corporation Law, Public Housing Law, Education Law, Labor Law, and Public Service Law. Several bills were laid aside, including a Public Health Law bill by Senator Fernandez and a Public Service Law bill by Senator Parker. The chamber also passed a concurrent constitutional resolution by Senator Stec proposing an amendment to Article 14. During floor debate, senators explained votes on several measures. Senator Ramos spoke in support of paid sick leave for domestic workers, describing the bill as a long-overdue labor protection for a workforce historically excluded from such rights. Senator Fernandez described her bill as the Manufacturer Disclosure and Transparency Act, aimed at requiring notice and public disclosure of certain pharmaceutical patent settlement agreements to improve transparency and competition in prescription drug pricing. Senator Ryan and Senator Martins supported a bill restricting hidden algorithmic price manipulation online, and Senator May supported a bill limiting excessive rental car fuel charges as part of a broader consumer protection package. The Senate also passed a memorial highway bill naming a portion of Route 19 in LeRoy for Lieutenant Gary A. Scott, with Senator Borrello explaining the veteran’s service and sacrifice.

Transcript Highlights:

• Drug and Pharmacy Benefit Managers Compliance.
• Implementation of the Prescription Drug Transparency Act.
• They are also protected from reporting rebate information for any specific drug product or drug class
• Drug clinics, that kind of thing.
• the top 25 drugs with the highest increase in total spending.

Committee: House Legislative Health & Human Services Committee

Transcript Highlights:

• Consider the data between Access to FDA-approved drugs that are safe and effective.
• Drug companies often keep these drug prices high by setting their own list prices and then offering co-pay
• Companies also use drug coupons to increase drug sales for a particular brand-name drug and to steer
• It's directly between the patient and the pharmacy and the drug company.
• She noted that the affordability of drug costs is important to everyone.

Committee: Senate Health

Summary: The committee heard several health-related bills, beginning with SB 1124 on lung cancer screening awareness. The author and supporters said the bill would require CDPH signage about lung cancer screening eligibility at tobacco point-of-sale locations to address low awareness and low screening rates. Support came from medical students, physicians, and the California Academy of Family Physicians, while retailers raised concerns about sign size, retailer notification, and implementation. Committee members generally supported the bill and noted the need to work through those concerns. SB 1150 sought to require clearer patient notice when cancer cases are reported to the California Cancer Registry. The author described the bill as a response to inconsistent notification practices and privacy concerns, and the chair and other members shared personal stories about learning they or family members were in the registry without knowing it. Cancer registry and university stakeholders expressed appreciation for amendments but continued to have concerns or wanted more time to review the language. The bill was discussed as a patient-awareness measure rather than a change to reporting requirements. The committee also heard SB 1400 on Alameda Health System governance, SB 1094 on biosimilar substitution and health plan policies, SB 1314 on smoke shop regulation and nitrous oxide restrictions, and SB 1309 on eliminating cost-sharing for medically necessary follow-up after lung cancer screening. SB 1400 and SB 1314 drew support from local officials, labor, and public health advocates, with members emphasizing youth protection and local oversight. SB 1094 passed after extensive debate over pharmacist substitution authority and notification requirements, with a 6-0 vote and opposition from biotechnology and physician groups. SB 1309 also passed after members discussed the cost of follow-up care and the value of early detection, despite opposition from health plans over premium impacts; it received a 7-0 vote and was placed on call.

Transcript Highlights:

• It is to have engaged voters who get to vote on their schedule.
• </c> voters who get to vote on their schedule voters who get to vote on their schedule without<03:43:
• It's a well-established standard practice to review risks, benefits, side effects, drug indications,
• It's a well-established standard practice to review risks, benefits, side effects, drug indications,
• It's a well-established standard practice to review risks, benefits, side effects, drug indications,

Summary: The House opened with prayer, the Pledge of Allegiance, the national anthem, leaves of absence, guest introductions, and memorial remarks honoring former Representative Carolyn Gargas of Hollis, who was remembered for her long House service, work on child and family issues, and community involvement. The House then adopted a consent calendar and approved a motion to withdraw House Bill 431, which would have created a commission to review draft rules on minimum standards for public school approval and state academic standards; the motion failed after a roll call vote, so the bill remained in play. The House next took up House Bill 109-FN, relative to false reports to law enforcement. The majority supported the bill as a way to add penalties for knowingly false reports about law enforcement officers, arguing officers deserve protection from false accusations and that the knowingly standard is a high bar. The minority opposed it as duplicative of existing law and warned it could chill legitimate complaints against police. After debate and a division vote, the majority committee report of ought to pass was adopted, 198-173. The House also considered House Bill 218-FN, which would provide victims of crime a free police report. The committee amendment changed the bill so victims would receive a written confirmation that a crime occurred rather than the initial police report, to avoid conflicts with right-to-know law and active-investigation confidentiality. Supporters said the change was a small but important clarification agreed to by law enforcement and domestic violence advocates, while opponents argued the original language was already workable and that the floor amendment was unnecessary. A division vote was requested on the amendment, and the transcript ends during that debate before the final outcome on HB 218 is shown.

Transcript Highlights:

• Um, theft often times feeds a drug addiction, uh, drug sale organization, um, and many other crimes are
• often times feeds a drug addiction, uh, drug<00:16:14.880><c> sale</c><00:16:15.600><c> organization
• These other drugs.
• Um, he's with the drug crimes.
• ><c> area,</c> highintensity drug trafficking area, highintensity drug trafficking area, which<00:38:

Bills: SF0007 , SF0008 , SF0009 , SF0010

Committee: Senate Judiciary

Transcript Highlights:

• As background, biological products are regulated by the federal Food and Drug Administration.
• products are manufactured, they cannot be replicated in the same way as traditional chemical-based drugs
• Under state and federal law, a pharmacist may substitute a brand-name drug or biological product with
• Instead, it authorizes a pharmacist to substitute a therapeutically equivalent drug or interchangeable
• And if all the biosimilars are preferred drugs, it should yield a lower cost sharing.

Committee: House Health Care & Wellness

Transcript Highlights:

• It's the 340B drug pricing program.
• I continue to believe at the federal level we should be negotiating drug prices on all drugs covered
• It's the 340B drug which is bipartisan. It's the 340B drug pricing<00:03:07.400><c> program.
• </c> years ago we passed a prescription drug years ago we passed a prescription drug affordability<00
• be negotiating drug prices on all<00:05:06.520><c> drugs</c><00:05:06.960><c> covered</c><00:05:07.240

Transcript Highlights:

• Access to FDA-approved drugs that are safe and effective.
• Drug companies often keep these drug prices high by setting their own list prices and then offering copay
• Companies also use drug coupons to increase drug sales for a particular brand-name drug.
• It's directly between the patient and the pharmacy and the drug company.
• That had been brought up versus, you know, perhaps a lower-cost drug.

Summary: The committee heard several health-related bills, beginning with SB 1124, which would require the California Department of Public Health to create and post lung cancer screening eligibility signage at tobacco point-of-sale locations. The author and supporters said the bill is intended to raise awareness of a screening that many eligible Californians do not know exists; retailers raised concerns about signage size, distribution, and notice to stores. The bill was presented while the committee lacked quorum, so no vote was taken at that time. Members then heard SB 1150, which would require clearer patient notice when cancer cases are reported to the California Cancer Registry. The author and committee chair emphasized patient awareness and privacy, while registry and university stakeholders said they appreciated the amendments and would continue working on the language. SB 1400 followed, proposing changes to Alameda Health System governance to give Alameda County more flexibility and direct oversight; county and labor supporters said the current structure is too rigid for today’s health care environment, and no opposition was heard. The committee also heard SB 1094, which would expand substitution of biosimilars and generics to lower prescription drug costs. Supporters, including health plans and Sharp Health Care, said the bill would reduce premiums and out-of-pocket costs, while opponents from biotechnology and rheumatology groups raised concerns about pharmacist substitution, patient switching, and therapeutic equivalence. After quorum was established, SB 1094 passed 6-0 and was re-referred to Appropriations. The committee then heard SB 1314, which would create a statewide definition for smoke shops, impose a 600-foot buffer from sensitive sites, and restrict nitrous oxide sales; it drew broad support from local government, pediatric, and law enforcement groups and passed 6-0 on call. SB 1309, which would eliminate cost-sharing for medically appropriate lung cancer screening follow-up care, also passed 7-0 and was re-referred to Appropriations after testimony from clinicians, advocates, and insurers. Finally, SB 1199 was introduced to ban copay accumulators, with the sponsor and author arguing it would ensure patient assistance counts toward out-of-pocket maximums and improve medication access.

Transcript Highlights:

• first up, GM544 submitting for consideration, um, Emily Andrade for the Hawaii Advisor Commission on Drug
• I'm the administrator of the alcohol and drug abuse division.
• So next up, GM545, Lilinoi Kavha Kawa Kawa Hikawa, um, for again drug abuse and controlled substances
• I'm the administrator of the alcohol and drug abuse division.
• </c> Drug Abuse and Controlled Substances. Drug Abuse and Controlled Substances.

Committee: Senate Health and Human Services

Summary: The Health and Human Services Committee heard and considered a series of gubernatorial nominations and reappointments, primarily to the Hawaii Advisory Commission on Drug Abuse and Controlled Substances, the State Council on Developmental Disabilities, the Hawaii Health Systems Corporation board, the Commission on Fatherhood, and the Policy Advisory Board for Elder Affairs. Testimony was overwhelmingly supportive across the measures. The Department of Health repeatedly testified in support of the drug and controlled substances nominees, and several nominees and supporters emphasized experience in public health, rural health access, disability advocacy, family services, and elder affairs. Some nominees were not present live but had submitted written answers, which the chair noted had been posted online. For the developmental disabilities nominations, testimony highlighted lived experience and representation from neighbor islands, with supporters saying the nominees would bring valuable perspectives and help strengthen services and advocacy. For the Hawaii Health Systems Corporation nominations, testimony stressed rural health, system collaboration, and broad community and hospital experience. The Commission on Fatherhood nominee said he wanted to advocate for fathers and be a voice for them, and supporters from Maui Family Support Services backed that nomination. The elder affairs nominee also received support from caregiver and aging-related organizations. At the end of the hearing, the committee moved to advise and consent on the nominations it had heard, and each recommendation was adopted by the members present. The chair noted that all members were present for the votes, and the meeting concluded with congratulations to the nominees and adjournment.

Transcript Highlights:

• </c> know I was drugged." know I was drugged."
• </c> convicted on five felony charges of drug convicted on five felony charges of drug trafficking.<03
• She needed to show that she'd been drugged, but nope, wouldn't do it.
• She needed to show that she'd been drugged, but nope, wouldn't do it.
• To show that she'd been drugged, but nope, wouldn't do it.

Committee: House Executive Departments and Administration

Transcript Highlights:

• This is House File 2242, the Medical Assistance Single PBM Prescription Drug Manual. management model
• The single PBM model also has constraints on the management of the drug benefit and essentially acts
• Virginia passed an SPBM Drug Benefit Management Model early in February of 2025.
• a drug product that cost $285.
• We are paying for the drugs at market price instead.

Committee: House Health Finance and Policy

Transcript Highlights:

• SB 490 by Umburg regarding alcohol and drug programs.
• drug spending over the last several years.
• drug spending over the last several years.
• The drug costs thousands of dollars per month.
• Drug companies often keep their drug prices high by setting their own list price, and they're offering

Summary: The Assembly Health Committee heard several measures, beginning with SB 331 by Sen. Menjivar, which would require large-group health plans to cover hearing aids for children. The author and supporters described the bill as a long-running effort to address a developmental emergency and reduce out-of-pocket costs for families, while opponents were absent. Testimony from parents, advocates, medical experts, and organizations emphasized the importance of early access to hearing aids; committee members voiced strong support, and the bill was moved on a do-pass basis to Appropriations, with several members requesting to be added as coauthors. The committee then heard SB 608, also by Sen. Menjivar, to expand access to condoms in school-based health centers and related settings and to prevent barriers such as ID checks. Supporters, including students and school health advocates, argued the bill would improve sexual health and reduce stigma, while opponents from family and faith groups argued it would undermine parental authority and normalize early sexual activity. The bill was supported by committee members and moved forward on a do-pass basis to Appropriations. Next, SB 971 by Sen. Choi proposed community-based healthy aging partnerships for older adults, with testimony from the California Senior Legislature and supporters from aging and dementia organizations. The measure was described as voluntary and focused on connection, independence, and local collaboration; there was no opposition, and the committee moved it on a do-pass basis to Appropriations. The committee also heard SB 869 by Sen. Weber Pierson, which would require warning icons and statements on chain restaurant menus for beverages with very high added sugar content. Supporters framed it as a transparency and public health measure, while restaurant and beverage industry representatives opposed it unless amended, citing cost and menu-space concerns; the bill was nevertheless moved on a do-pass basis to Appropriations after a roll call vote, with some members voting no and the measure placed on call. The committee also considered SB 950 by Sen. Weber Pierson, aimed at ensuring timely coverage of FDA-approved, medically necessary treatments for early-onset Alzheimer’s disease on commercial plans. Supporters, including the Alzheimer’s Association and a patient advocate, said the bill would reduce delays and barriers to care, while health plan representatives opposed it over step therapy and utilization-management concerns. Members discussed the limited treatment window and the need for early access, and the bill was moved on a do-pass basis to Appropriations. In addition, SB 490 by Sen. Umberg would set timelines for DHCS investigations of unlicensed sober living homes and allow counties to assist if the department cannot act in time; supporters from Anaheim and a patient-brokering survivor described serious abuse and oversight gaps, while county behavioral health representatives opposed the county role as an unfunded and potentially liability-creating burden. After discussion, the bill was also moved on a do-pass basis to Appropriations. Finally, the committee began hearing SB 1037 by Sen. Weber Pierson on health insurance affordability and rate review, with supporters arguing it would tie premium increases more closely to affordability targets and public reporting; the transcript cuts off before the committee completed action on that measure.

Transcript Highlights:

• So I mean these drugs are economy.
• And the these drugs to their capability.
• Berg has said over here with some of the relative merits of GLP-1 drugs.
• </c> GLP-1 drugs. GLP-1 drugs.
• </c><00:10:34.800><c> in</c> highest profit margins of any drug in highest profit margins of any drug

Committee: Senate Licensing & Occupations

Transcript Highlights:

• It's also important to note that drug rebates are not the primary contributor to higher drug prices.
• that the drug rebate process acknowledge that the drug rebate process isn't<01:35:33.239><c> perfect
• nothing about the drug changed.
• </c><01:42:08.440><c> not</c> won't be eligible for all drugs not won't be eligible for all drugs not
• are about 10% of the amount brand drugs are about 10% of the amount of<01:42:17.320><c> drugs</c><01

Committee: House Health

Summary: The committee first took up SB 1494 on hearing aids. Testimony was generally supportive of expanding hearing-aid coverage, with the Insurance Division raising concern about possible federal defrayment issues, SHPDA supporting the goal of hearing augmentation, DCAB strongly supporting the bill as an important access issue, and health plans and insurers asking for amendments. Kaiser Permanente and the Hawaii Association of Health Plans requested changes to add a medical-necessity standard and clarify annual notice language, while HMSA suggested the proposal should be studied by the auditor. The chair noted concerns about federal preemption and the lack of an audit, and deferred the bill in favor of a related resolution calling for a study. The committee then heard SB 1448, an emergency appropriation for the Hawaii State Hospital. DAGS and the Department of Health supported the measure, with the hospital administrator saying the funding would improve the environment of care, support cleaning, and allow a third-party review of the building. Committee members questioned the size of the request and the status of litigation against the design-builder. Administration witnesses said they were pursuing a comprehensive study involving destructive testing, had made a demand on the design-builder to fund the study, and were using different processes than before. They also said the roof work would be handled through a separate CIP request. No final action was taken in the portion provided. The committee next heard SB 1432, relating to the future responsibilities of the Department of Health and land issues at Kalaupapa after the last patient dies. DOH supported the bill in part but said its long-term role would be limited mainly to environmental cleanup, with operations expected to continue under the National Park Service and land-use decisions left to DHHL and beneficiary consultation. DHHL asked that the measure reflect that any land-use or zoning changes on homeland lands require commission approval and beneficiary consultation. Testifiers from Kalaupapa and Maui County, including Degra Vanderbilt-Papa and Council Member Keani Rollins-Fernandez, supported deferring the bill, saying there had been no meaningful community discussion about provisions affecting Kalaupapa’s future management and possible transfer of responsibilities to Maui County. The committee also read into the record written testimony from Gloria Marks emphasizing that Kalaupapa stakeholders must be included in future discussions. Finally, the committee heard SB 955 on fitness-to-proceed examinations. The Judiciary and the Public Defender’s Office both supported raising pay and standardizing expectations for private examiners, but opposed reducing felony fitness evaluations from three examiners to one and opposed expanding use of expedited reports. They argued that a single examiner would reduce reliability, create a more adversarial process, and likely increase costs and contested hearings, while expedited reports do not contain enough information for a proper fitness determination. The Department of Health also supported the bill’s intent but asked to preserve a three-examiner framework and said the goal was to reduce the number of people sent to the State Hospital, where admissions have reportedly risen about 20% year over year since Act 26. The bill remained under discussion in the excerpt, with no final vote shown.

Transcript Highlights:

• If somebody had MS and they had already gone through different drugs, but one drug in particular harmed
• Gone through different drugs, but one drug in particular harmed them and made them sicker, or one in
• You're talking about some very serious drugs and removing prior authorization for those drugs.
• You're talking about some very serious drugs, and removing prior authorization for those drugs is a concern
• You're talking about some very serious drugs, and removing prior authorization for those drugs is a concern

Summary: The committee first took up Senate Bill 20, a prior-authorization measure aimed at exempting certain medications and treatments for seriously mentally ill adults from repeat insurance prior authorization, while also extending prior authorization approvals to three years for chronic maintenance drugs. The sponsor described the bill as the latest in a series of bipartisan prior-authorization reforms and accepted an amendment from the Health Care Authority and the Office of the Superintendent of Insurance to apply the bill to adults only and to cover PBMs in the interagency purchasing collaborative. Supporters, including NAMI New Mexico and state health officials, argued the bill would reduce barriers to needed care, especially for mental health treatment. Opponents from health plans, PBMs, and insurers warned the bill was too broad, lacked clear definitions for serious mental illness and chronic conditions, created patient-safety concerns, and should have a shorter reauthorization period and later implementation date. After committee discussion, the sponsor agreed to work on a committee substitute, and the bill was rolled over for a later meeting. The committee then heard Senate Bill 53, the Chispa data privacy bill, which would impose broad limits on the collection, sale, and use of personal data, require opt-in consent for many uses, strengthen rights to access, correct, and delete data, and create enforcement mechanisms including a private right of action. Supporters from advocacy, women’s, behavioral health, reproductive health, and civil rights groups said the bill was needed to protect sensitive health and location data, prevent surveillance and criminalization, and give New Mexicans real control over their information. Business, technology, insurance, and hospital representatives opposed the bill, arguing it was more restrictive than other states’ privacy laws, would burden small businesses and health-related services, create compliance uncertainty, and risk limiting digital services and innovation. After extensive questioning about data breaches, opt-in consent, nonprofit exemptions, and the bill’s impact on businesses and health care access, a motion to table failed 5-4, and the committee then passed SB 53 on a 5-4 vote. The committee next heard Senate Bill 86, which updates the state’s harassment-by-telephone law to cover electronic communications such as social media, messaging apps, and email. The sponsor and a Las Cruces police chief said the change would modernize an outdated 1967 statute and help law enforcement address harassment and domestic violence through current technology. The bill drew support from the governor’s public safety advisor and the Greater Albuquerque Chamber of Commerce, and members asked a few clarifying questions about the wording. The committee approved SB 86 unanimously, 9-0. Finally, the committee began hearing Senate Bill 96, on regulated childcare zoning requirements, using a committee substitute. The sponsor and the Early Childhood Education and Care Department said the bill would reduce confusing zoning and fire-code barriers to opening or expanding child care homes and centers, helping address a statewide shortage of child care slots and supporting working families. The discussion began with the committee substitute and an explanation that the measure is intended to streamline local requirements and expand child care supply.

Transcript Highlights:

• on our preferred drug list, or PDL.
• </c> what drugs are on our preferred drug what drugs are on our preferred drug list<01:13:36.000><c>
• </c> proposal would be through uh 340b drug proposal would be through uh 340b drug pricing<01:15:07.239
• uh rebate revenue for prescription drug uh rebate revenue for those<01:15:25.000><c> drugs</c><01:15
• </c><01:15:34.600><c> rebate</c> Medicaid prescription drug rebate Medicaid prescription drug rebate

Committee: House Health Finance and Policy

Transcript Highlights:

• Any drug or device is very concerning to me as a pro-life legislator.
• drug that would induce an abortion.
• Food and Drug Administration. That might cause concern as well. There might be some drugs.
• That's what you're doing by taking off that abortion-inducing drug.
• So for the one drug, there is the world. the 120 days assault window.

Committee: House Crime and Public Safety

Summary: The committee first met in executive session and took up House Bill 3174 by Representative Justice. Members adopted two committee amendments: one removed the bill’s mapping provisions so that the vendor-list portion could move forward separately, and another required schools to have at least one master key box for emergency responders. The amendments were rolled into a committee substitute, which the committee then voted do pass on a 10-0 roll call. A second executive-session bill was postponed until the following week because of a family emergency involving Representative Williams. The committee then heard Senate Bill 982, a cleanup and reorganization bill dealing with Missouri’s sex offender registry and related registration rules. Senator Mary Elizabeth Coleman said the bill was intended to align the registry statutes with prior changes, clarify tiering and registration requirements, address offenders with ties to Missouri but living elsewhere, and improve information-sharing rules for law enforcement and victims, including notice when a registrant dies or moves. Testimony in support came from the Missouri Alliance for Family Restoration, which said the bill codifies case law and reduces administrative confusion for the Highway Patrol and registrants. No opposition was offered. The committee also heard House Bill 3414, which would create a state offense modeled on a federal online-fraud law to help law enforcement pursue internet-based fraud, including schemes involving credit cards, account numbers, telecommunication identifiers, and similar access devices. The sponsor and a law-enforcement witness said the bill would give investigators another tool against increasingly common fraud, including elder fraud and VoIP-based schemes; a Maverick convenience stores representative also supported it as a response to changing technology. No opposition was presented. Finally, the committee heard House Bills 2628 and 3460, the CARE Act, which would require hospitals and health facilities treating sexual-assault survivors to inform patients about emergency contraception, provide it if requested, test and treat for sexually transmitted infections, and seek reimbursement through the Department of Public Safety. Sponsor Jacqueline Zimmerman said the bill is meant to reduce trauma and prevent pregnancies resulting from rape, and witnesses from sexual-assault nursing, reproductive-health, anti-poverty, medical, and nursing organizations supported it as a way to standardize care, especially in rural areas. Several members raised questions about whether the bill would require abortion-inducing drugs, whether hospitals could opt out on conscientious grounds, and how reimbursement would work; the sponsor said she intended to add language excluding abortion-inducing medications and that the current DPS forensic-exam payment structure would not change. No votes were taken on the later bills in the portion of the transcript provided.

Transcript Highlights:

• In addition to preventing overdose, these centers are shown to reduce public drug use, drug-related litter
• It's still a problem with the drug war because we're not winning it, in my opinion.
• drug war.
• use and address the demand for drug use.
• And fentanyl is the leading drug involved in overdoses.

Summary: The committee first took up House Bill 12, the physical therapy licensure compact. The sponsor and supporters said the bill would increase access to care and help recruit physical therapists in New Mexico, especially in rural areas and for neurodivergent patients. Support came from the Greater Albuquerque Chamber of Commerce, Desert States Physical Therapy Network, Think New Mexico, the state Health Care Authority, and Americans for Autism Advocacy. A trial lawyer raised concerns about immunity, venue, and loser-pays language, and committee members discussed whether New Mexico-specific amendments would be accepted by the compact commission. Two amendments were adopted, including clarifying language on background checks, data, federal court standing, and repeal procedures, plus an immunity-related amendment. The bill was then reported out with a 9-0 due pass recommendation. The committee then considered House Bill 10, the physician assistant interstate compact. Supporters again emphasized workforce shortages, telehealth access, and the need to join the compact to qualify for Rural Health Transformation Program funding. The Health Care Authority said the compact was part of New Mexico’s commitments tied to federal funding, and a trial lawyer again raised concerns about loser-pays language. Two amendments were adopted to clarify New Mexico’s authority over reproductive and gender-affirming care issues, confidentiality of New Mexico licensee data, joint investigations, and contingent repeal procedures. After discussion about malpractice exposure, oversight, and the need for compact commission approval of language changes, the bill received an 8-0 due pass recommendation. House Bill 34, dealing with school nurse licensure provisions, was presented as a cleanup bill to clarify implementation issues from last session. The changes would add charter schools, align contract language with teacher contracts, and adjust supervision and evaluation rules for tiered school nurses in small districts. The New Mexico School Nurses Association supported the bill, and it passed unanimously with an 8-0 due pass recommendation. The committee also heard Senate Memorial 21, which would direct the Department of Health to study overdose prevention centers and other harm reduction strategies. Supporters from the ACLU, All Safe New Mexico, the Drug Policy Alliance, and Families and Youth Innovations Plus argued that New Mexico’s overdose crisis remains severe and that evidence-based interventions could save lives and connect people to treatment. The Department of Health provided background on overdose trends and said it was neutral but available for technical questions. After discussion about fentanyl trends, drug prices, and public health approaches, the memorial was approved on a 7-1 due pass vote. The committee also announced that Senate Bill 130 would be rolled over to Sunday’s meeting because a new substitute needed review.

Transcript Highlights:

• No, I think what I'm saying is I think there needs to be an effort to accommodate parents' schedules,
• No, I think what I'm saying is I think there needs to be an effort to accommodate parents' schedules,
• No, I think what I'm saying is I think there needs to be an effort to accommodate parents' schedules,
• We do try to schedule that way. Sometimes the bills trickle into when they get assigned.
• </c> pharmaceutical drugs on school grounds. pharmaceutical drugs on school grounds.

Summary: The House Education Policy and Administration Committee met to hear a non-germane amendment to House Bill 131, which concerns bullying and cyberbullying prevention. Representative Glenn Cordelli, the prime sponsor, said the amendment was intended to revise and improve language from last year’s SB 210 and to incorporate measures from a cyberbullying bill previously passed by the House. He described changes to school communication requirements, mandatory reporting of bullying and retaliation, stronger investigation and collaboration requirements for cross-district cases, added safety and remediation language, a required conference with the alleged perpetrator and parents if available, updated reporting deadlines, and disciplinary consequences for harassment, intimidation, retaliation, and false reports. He also noted a later amendment would be needed to insert the words “the perpetrator” in one section, and he explained that some changes were meant to align with prior legislation and legislative drafting suggestions. Committee members raised several concerns. Representative Murray questioned the treatment of private and parochial schools, the change from gross negligence to negligence, and the removal of a definition of bullying based on imbalance of power and perceived characteristics. Representative Damon also objected to deleting that definition, arguing it would narrow the scope of bullying too much. Representative Han spoke in opposition, saying the amendment was too broad, unnecessary in parts, and not ready for final action; he criticized the removal of the imbalance-of-power language, the conference requirement when parents may not participate, and the reporting obligations for bus drivers and others. Cordelli responded that some issues were already addressed in prior law or SB 210 and that private schools have their own policies. Michelle Wongran of New Hampshire Legal Assistance testified in opposition, saying the bill was being heard without enough notice and that it does far more than the committee analysis suggests. She said the amendment adds undefined retaliation language, imposes reporting duties on school vendors and contractors, may conflict with FERPA and other federal privacy rules, and includes provisions that could have serious implications for schools and students. She said she supports parental involvement and some conference provisions in concept, but urged the committee to reject the amendment or at least send it through the normal legislative process for fuller review. No vote was taken during the hearing portion described in the transcript.

Transcript Highlights:

• of drugs for consumer use.
• 2022, the federal FDA Modernization Act 2.0 removed the mandatory animal testing requirement for new drug
• Also, in 2025, the FDA announced plans to phase out animal testing for certain drugs as well.
• It will offer humans the most accurate results and understanding of a product or drug.
• However, the federal Food and Drug Administration has not yet finalized regulations for drug approval

Summary: The committee held public hearings on several bills. House Bill 2542 would require drug developers to use validated non-animal testing methods when available, unless federal regulators request animal testing. The sponsor said the bill builds on prior Washington action on cosmetics testing and is intended to move toward more humane and modern science. Supporters, including students, animal welfare advocates, and biotech-related witnesses, argued that animal tests often fail to predict human outcomes and that alternatives are more accurate. A biotech industry representative said animal testing is still necessary for some research and warned the bill could deter local innovation, but said the industry was open to amendments. The sponsor said she was open to discussing changes to the enforcement mechanism. No vote was taken on the bill during the hearing. House Bill 2629 would address theft and vandalism of critical communications infrastructure, including copper and fiber lines. The bill would ban cash payments for nonferrous metal transactions, require electronic or stored-value payment methods, impose civil penalties for stolen copper used in telecommunications cable, and create a new Class C felony for destruction of critical communications infrastructure. The sponsor and industry witnesses described repeated outages affecting 911, hospitals, schools, and first responders, and said Washington has a high rate of these incidents. Recycling industry representatives supported the bill after negotiations, but a prosecutor and some others said the bill should focus more on law enforcement tools such as searchable transaction databases and holding periods rather than new penalties. No final action was taken in the hearing. House Bill 2394 would expand the Insurance Commissioner’s insurance fraud program and create a Class B felony for insurance fraud, including fraudulent billing, misrepresentation of repair costs, and misuse of coding systems. The bill also broadens who can be considered a victim for restitution and gives the commissioner additional investigative tools, while the substitute removed a reporting duty for certified public accountants. The sponsor and the Insurance Commissioner’s office said the measure responds to more sophisticated, technology-driven fraud schemes that harm both insurers and consumers. Insurance industry and fraud bureau witnesses supported the bill as a consumer protection measure. No vote was taken. House Bill 2361 would raise the maximum principal amount for small loans from $700 to $1,200, with annual inflation adjustments, while keeping the existing 30% of monthly income cap and other safeguards. The sponsor said the change would better reflect emergency costs and help borrowers avoid illegal lenders. DFI raised implementation questions about inflation adjustments and publication requirements, and opponents from AARP, SEIU 775, poverty advocates, and consumer attorneys argued the bill would increase debt traps and fees for low-income borrowers and older adults. MoneyTree supported the bill, saying the current cap is outdated and that the product remains a flat-fee, regulated credit option with existing consumer protections. The hearing also included testimony on House Bill 2294, which would prohibit negative use restrictions on real property that block grocery stores or pharmacies; staff described a proposed amendment adding notice and changing enforcement, and the committee then moved the bill out with a due pass recommendation.